BTS Secures Top American Music Awards Honor for Second Consecutive Year
US Productivity Growth Cools in Q4 as Labor Costs Rise Stirring Inflation Concerns
Ethereum Treasury Firms See Staking Revenue Surge to 60 of Total Income
US and China Trade Rifts Persist After TrumpXi Summit APEC Signals Show
Myanmars Political Transition Requires Press Freedom Benchmarks CPJ Urges
SpaceXs Starship V3 Debuts in Milestone Test Flight Carrying Mock Satellites
DBGI Q3 2023 Earnings Significant Loss Per Share Amid Stock Decline
RILYK Q1 2024 Earnings Net Loss Deepens Senior Notes Edge Higher
PIII Q1 2026 Earnings Massive EPS Beat Drives Surprise Profitability Yet Stock Declines
MillerKnoll Q1 2026 Earnings EPS Misses Estimates Amid Softening Demand
Purple Biotech Ltd PPBT Q1 2025 Earnings PreRevenue Biotech Reports Narrower Loss as Clinical Progress Continues
FrontView REIT FVR Q1 2026 Earnings Strong Earnings Beat Driven by Operational Efficiency
Hennessy Capital Investment Corp VII Rights HVIIR Gains 3 as Support Holds Near 035
Montauk Renewables MNTK Gains 42 as Renewable Energy Stock Finds Support Near 153
British American Tobacco BTI Declines 14 as Key Support Levels Loom
Luda Technology Group LUD Declines 818 as Shares Test Key Support Levels
United Bankshares UBSI Edges Higher as Support Holds Steady
Daiwa Upgrades Bloom Energy to Outperform Amid Clean Energy Momentum
NVR Q1 2026 Earnings EPS Misses Estimates Amid Challenging Market Conditions
Global Interactive Technologies GITS Slips 289 as Support Level Comes into Focus
RITM Q1 2026 Earnings Modest EPS Beat Highlights Stability in Mortgage Real Estate
FBRX Q1 2026 Earnings PreRevenue Biotech Reports Narrow EPS Miss Amid Ongoing Development
Aktis Oncology AKTS Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Advances Pipeline
Ouster Q1 2026 Earnings EPS Beats Estimates Amid Unclear Revenue Picture
OCS Q1 2026 Earnings EPS Misses Estimates as Biotech Firm Continues RD Investments
RGA Q1 2026 Earnings Strong EPS Beat Driven by Favorable Underwriting Results
RNXT Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline